Pulmonary Disease, Chronic Obstructive
"Pulmonary Disease, Chronic Obstructive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Descriptor ID |
D029424
|
MeSH Number(s) |
C08.381.495.389
|
Concept/Terms |
Airflow Obstruction, Chronic- Airflow Obstruction, Chronic
- Airflow Obstructions, Chronic
- Chronic Airflow Obstructions
- Chronic Airflow Obstruction
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Disease, Chronic Obstructive".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Disease, Chronic Obstructive".
This graph shows the total number of publications written about "Pulmonary Disease, Chronic Obstructive" by people in this website by year, and whether "Pulmonary Disease, Chronic Obstructive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2004 | 2 | 0 | 2 |
2005 | 1 | 4 | 5 |
2006 | 2 | 0 | 2 |
2007 | 2 | 0 | 2 |
2008 | 1 | 3 | 4 |
2009 | 3 | 2 | 5 |
2010 | 5 | 5 | 10 |
2011 | 7 | 4 | 11 |
2012 | 7 | 2 | 9 |
2013 | 3 | 1 | 4 |
2014 | 7 | 0 | 7 |
2015 | 3 | 0 | 3 |
2016 | 7 | 2 | 9 |
2017 | 12 | 3 | 15 |
2018 | 10 | 3 | 13 |
2019 | 15 | 0 | 15 |
2020 | 19 | 5 | 24 |
2021 | 14 | 1 | 15 |
2022 | 17 | 0 | 17 |
2023 | 15 | 2 | 17 |
2024 | 9 | 1 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulmonary Disease, Chronic Obstructive" by people in Profiles.
-
Echocardiography Findings for Pulmonary Hypertension During Workup for Bronchoscopic Lung Volume Reduction. J Bronchology Interv Pulmonol. 2025 Jan 01; 32(1).
-
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2024 Nov 15; 210(10):1210-1218.
-
Reduced Cost Sharing and Medication Management Services for COPD: A Randomized Clinical Trial. JAMA Intern Med. 2024 Oct 01; 184(10):1186-1194.
-
A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2024 Sep 15; 210(6):715-729.
-
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024 07 15; 210(2):186-200.
-
Determining If COPD Self-Management Televisit-Based Interventions Are Evaluated Among and Equitably Effective Across Diverse Patient Populations to Reduce Acute Care Use: A Scoping Review. Chest. 2024 Dec; 166(6):1371-1393.
-
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort. JCI Insight. 2024 Jun 24; 9(12).
-
Real-world treatment trajectories of adults with newly diagnosed asthma or COPD. BMJ Open Respir Res. 2024 02 27; 11(1).
-
Efficacy and safety of the Spiration Valve Systemâ„¢ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE). Respir Med. 2024 04; 224:107565.
-
Trailblazing Clinical Trials in Asthma, COPD, Sleep Medicine, and Education and Clinical Practice in 2023. Chest. 2024 01; 165(1):19-21.